Forest Laboratories was an American pharmaceutical company headquartered in New York City. The companys research and development spending had grown rapidly in recent years and, as of 2007, approached almost a billion U.S. dollars a year, which put it on the list of the top 100 global corporations in R&D spending. Forest Laboratories was also known for licensing European pharmaceuticals for sale in the United States. The company also had offices in St. Louis, Cincinnati, Jersey City, Oakland, Dublin, Kent and Paris. In January 2014, Forest agreed to acquire Aptalis Pharma for $2.9 billion in order to gain access to treatments for gastrointestinal ailments and cystic fibrosis. In February 2014, Actavis announced it would acquire Forest Laboratories for around $25 billion.